The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Vitamin D Treatment in Primary Hyperparathyroidism: A Randomized Placebo Controlled Trial
Open accessAbstract
CONTEXT: Low 25-hydroxyvitamin D levels are common in patients with primary hyperparathyroidism (PHPT) and associated with higher PTH levels and hungry bone syndrome after parathyroidectomy (PTX). However, concerns have been raised about the safety of vitamin D supplementation in PHPT. OBJECTIVE: We aimed to assess safety and effects on calcium homeostasis and bone metabolism of supplementation with high doses of vitamin D in PHPT patients. DESIGN, SETTING: This was an investigator-initiated double-blind, randomized, placebo-controlled, parallel-group trial from a single center. PATIENTS: Forty-six PHPT patients were recruited, with a mean age of 58 (range 29-77) years, and 35 (76%) were women. INTERVENTIONS: Intervention included daily supplementation with 70 μg (2800 IU) cholecalciferol or identical placebo for 52 weeks. Treatment was administered 26 weeks before PTX and continued for 26 weeks after PTX. MAIN OUTCOME MEASURES: PTH, calcium homeostasis, and bone metabolism were evaluated. RESULTS: Preoperatively, 25-hydroxyvitamin D increased from 50 to 94 nmol/L in the treatment group and decreased from 57 to 52 nmol/L in the placebo group (P < .001). Compared with placebo, vitamin D decreased PTH significantly by 17% before PTX (P = .01), increased lumbar spine bone mineral density by 2.5% (P = .01), and decreased C-terminal β-CrossLaps by 22% (P < .005). The trabecular bone score did not change in response to treatment, but improved after PTX. Postoperatively, PTH remained lower in the cholecalciferol group compared with the placebo group (P = .04). Plasma creatinine and plasma and urinary calcium did not differ between groups. CONCLUSIONS: Daily supplementation with a high vitamin D dose safely improves vitamin D status and decreases PTH in PHPT patients. The vitamin D treatment is accompanied by reduced bone resorption and improved bone mineral density before operation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects
the Scientific Committee of the GRIO (Groupe de Recherche et d’Information sur les Ostéoporoses), Bousson, V., Bergot, C., Sutter, B., Levitz, P., & Cortet, B. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1824-6 · Cited by 250
Cited by
Bilezikian, J. P., Khan, A. A., Silverberg, S. J., Fuleihan, G. E.-H., Marcocci, C., Minisola, S., Perrier, N., Sitges-Serra, A., Thakker, R. V., Guyatt, G., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4677 · Cited by 602
Walker, M. D., & Silverberg, S. J. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.104 · Cited by 566
Khan, A. A., Hanley, D. A., Rizzoli, R., Bollerslev, J., Young, J. E. M., Rejnmark, L., Thakker, R., D’Amour, P., Paul, T., Van Uum, S., et al. (2017) · Osteoporosis International · doi:10.1007/s00198-016-3716-2 · Cited by 544
Self-citationBolland, M. J., Grey, A., & Avenell, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30265-1 · Cited by 436
Silva, B. C., Broy, S. B., Boutroy, S., Schousboe, J. T., Shepherd, J. A., & Leslie, W. D. (2015) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2015.06.008 · Cited by 331
Metadata
- Authors
- Rolighed, L., Rejnmark, L., Sikjaer, T., Heickendorff, L., Vestergaard, P., Mosekilde, L., & Christiansen, P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-03-01
- Volume
- 99
- Issue
- 3
- Pages
- 1072-1080
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2151478261
- Cited by
- 186
- References
- 2
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin D Treatment in Primary Hyperparathyroidism: A Randomized Placebo Controlled Trial. https://app.cochat.ai/papers/10.1210/jc.2013-3978
- The paper
- Rolighed, L., Rejnmark, L., Sikjaer, T., Heickendorff, L., Vestergaard, P., Mosekilde, L., & Christiansen, P. (2014). Vitamin D Treatment in Primary Hyperparathyroidism: A Randomized Placebo Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-3978
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.